Erasca
eras a potent inhibitor with a over fold higher than approved inhibitors was specifically designed to inhibit in actin | Erasca
Company
Deck date
January 2024
Slide
31 of 41
Similar slides by Erasca
Investor Presentation
November 2023
Investor Presentation
August 2023
Other recent decks by Erasca
Investor Presentation
November 2023
Investor Presentation
August 2023
IPO
July 2021
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io